Dr. Coppolecchia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Bayer Blvd
Whippany
Whippany, NJ 07981Phone+1 862-404-4984
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Occupational and Environmental Medicine, 1996 - 1998
Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 1993 - 1996
Rowan University School of Osteopathic MedicineClass of 1992
Certifications & Licensure
NJ State License 1993 - 2025
NY State License 2004 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 516 citationsUse of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlle...J. Michael Gaziano, Carlos Brotons, Rosa Coppolecchia, Claudio Cricelli, Harald Darius
Lancet. 2018-09-22 - 65 citationsA Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse...Sunil V Rao, Bodo Kirsch, Deepak L Bhatt, Andrzej Budaj, Rosa Coppolecchia
Circulation. 2022-10-18 - 4 citationsBleeding Outcomes in Patients Treated With Asundexian in Phase II Trials.John W Eikelboom, Hardi Mundl, John H Alexander, Valeria Caso, Stuart J Connolly
Journal of the American College of Cardiology. 2024-02-13
Professional Memberships
- Fellow
- Member
- Fellow
- Fellow
Other Languages
- Italian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
